Streptococcus agalactiae in Farmed Tilapia: Clinical Outbreaks and Molecular Detection

Introduction

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a Gram-positive coccus that causes significant economic losses in global tilapia aquaculture [1, 2, 3]. The bacterium is a primary etiological agent of streptococcosis in both Nile tilapia (Oreochromis niloticus) and red tilapia (Oreochromis spp.), leading to high morbidity and mortality in intensive farming systems [4, 5, 6]. S. agalactiae infections in tilapia are characterized by meningoencephalitis, septicemia, and exophthalmia, with outbreaks often triggered by environmental stressors such as elevated water temperature and poor water quality [7, 8]. The pathogen exhibits considerable genetic diversity, with multiple serotypes and sequence types (STs) circulating across different geographic regions [2, 3, 9]. Molecular detection methods, including polymerase chain reaction (PCR) and multilocus sequence typing (MLST), have become essential for rapid diagnosis and epidemiological surveillance [10, 11, 12]. This article provides a detailed review of clinical outbreaks and molecular detection of S. agalactiae in farmed tilapia, drawing on peer-reviewed literature from Latin America, Asia, Africa, and Australia.

Clinical Outbreaks and Disease Expression

Host Susceptibility and Age-Dependent Disease

Clinical outbreaks of S. agalactiae in tilapia are strongly influenced by host age and immune status. Rozas-Serri et al. [1] demonstrated that in Latin American farmed Nile tilapia, disease expression is age-dependent, with younger fish (fingerlings and juveniles) exhibiting higher mortality rates and more acute clinical signs compared to older fish. Subclinical infections are also common, particularly in adult fish, where inapparent carriers can maintain the pathogen within the population [7]. Owatari et al. [7] reported that histopathological and hematological analyses of asymptomatic tilapia revealed chronic inflammatory lesions in the spleen and kidney, suggesting that inapparent infections contribute to ongoing mortality without overt clinical signs.

Environmental Triggers and Outbreak Dynamics

Outbreaks of streptococcosis typically occur when water temperatures exceed 28°C, as S. agalactiae proliferates rapidly under warm conditions [8]. High stocking densities, low dissolved oxygen, and elevated ammonia levels further predispose fish to infection [6]. In a case study on a red tilapia farm in Colombia, Hernández et al. [6] documented an outbreak with cumulative mortality exceeding 40% over a three-week period, correlating with a sudden rise in water temperature and poor water exchange. Similar outbreak patterns have been reported in Thailand [4], the Philippines [5], and China [12], indicating that environmental management is critical for disease prevention.

Clinical Signs and Pathology

Affected tilapia present with a range of clinical signs, including lethargy, erratic swimming, exophthalmia (unilateral or bilateral), corneal opacity, abdominal distension, and hemorrhages at the base of fins and around the mouth [5, 13, 8]. Internally, gross lesions include meningoencephalitis (congestion and hemorrhage in the brain), splenomegaly, renomegaly, and accumulation of serosanguinous fluid in the peritoneal cavity [6, 8]. Histopathological examination reveals severe meningitis, perivascular cuffing in the brain, necrosis of hepatocytes, and granulomatous inflammation in the spleen and kidney [7, 8]. Mian et al. [8] described the natural history of S. agalactiae infection in Nile tilapia, noting that bacterial colonization of the central nervous system occurs within 24 hours of intraperitoneal challenge, leading to rapid onset of neurological signs.

Serotype and Sequence Type Diversity

S. agalactiae isolates from tilapia belong to multiple serotypes, including Ia, Ib, II, III, and VII [1, 2, 3, 14]. Serotype Ia ST7 CC1 has emerged as a dominant clonal lineage in Latin America, causing age-dependent disease expression [1]. In Brazil, Assane et al. [2] characterized isolates from mass mortality events and identified serotypes Ia, Ib, and III, with a high prevalence of virulence genes such as scpB, lmb, and fbsA. In Southeast Asia, Barkham et al. [9] reported that a hypervirulent clone, sequence type 283 (ST283), accounts for a large proportion of invasive S. agalactiae isolated from both diseased tilapia and humans, highlighting the zoonotic potential of certain lineages. Kawasaki et al. [15] described the microevolution of ST-261 in Australia, suggesting dissemination via imported tilapia and ongoing adaptation to marine hosts. Serotype VII has been identified as an emerging pathogen in snakeskin gourami (Trichogaster pectoralis) in Thailand, indicating that S. agalactiae can infect a range of fish species beyond tilapia [14].

Molecular Detection Methods

Conventional and Multiplex PCR

Rapid and accurate identification of S. agalactiae is essential for outbreak management. Conventional PCR targeting species-specific genes, such as the cfb gene (encoding CAMP factor) or the 16S rRNA gene, is widely used [11, 12]. Abdelsalam et al. [11] developed a PCR assay for rapid identification of pathogenic streptococci from moribund red tilapia, achieving high sensitivity and specificity. Multiplex PCR assays allow simultaneous detection of multiple pathogens in a single reaction. Diyie et al. [10] used a multiplex PCR panel to detect S. agalactiae, S. iniae, and Lactococcus garvieae in cultured fish in Ghana, demonstrating the utility of this approach for rapid differential diagnosis. Chen et al. [12] employed PCR combined with pulsed-field gel electrophoresis (PFGE) to genotype S. agalactiae isolates from tilapia in China, revealing genetic heterogeneity among outbreak strains.

Genotyping and Molecular Epidemiology

Molecular typing methods, including MLST and PFGE, are critical for tracking the spread of virulent clones. Pereira et al. [16] genotyped S. agalactiae strains from fish, humans, and cattle, and assessed their virulence potential in Nile tilapia, finding that fish-derived strains were highly pathogenic in experimental infections. Sirimanapong et al. [3] conducted a large-scale study on the geographical, temporal, and host-species distribution of potentially human-pathogenic GBS in aquaculture species in Southeast Asia, identifying ST283 as the predominant sequence type in both fish and human isolates. Pulpipat et al. [14] used MLST to characterize serotype VII isolates from snakeskin gourami, revealing a novel sequence type associated with intensive farming. Jantrakajorn et al. [4] characterized S. agalactiae and L. garvieae from red tilapia in Thailand using PCR and antimicrobial susceptibility testing, finding that S. agalactiae isolates were predominantly serotype Ia.

Diagnostic Workflow

The following Mermaid diagram illustrates a typical diagnostic workflow for S. agalactiae detection in tilapia, from clinical sample collection to molecular confirmation.

flowchart TD
 A["Clinical sample: brain, kidney, spleen"] --> B[Gram stain & culture on blood agar]
 B --> C[Catalase-negative, Gram-positive cocci]
 C --> D[PCR targeting cfb or 16S rRNA]
 D --> E{Positive for S. agalactiae?}
 E -->|Yes| F[Serotyping by multiplex PCR or latex agglutination]
 E -->|No| G["Consider other pathogens: S. iniae, L. garvieae"]
 F --> H[MLST or PFGE for epidemiological typing]
 H --> I[Antimicrobial susceptibility testing]
 I --> J[Report and outbreak management]

Antimicrobial Susceptibility and Resistance

Antimicrobial resistance (AMR) in S. agalactiae from tilapia is a growing concern. Rozas-Serri et al. [1] reported that Latin American isolates of serotype Ia ST7 CC1 were susceptible to florfenicol, oxytetracycline, and amoxicillin, but resistance to erythromycin and clindamycin was observed in some strains. Hassan et al. [17] characterized bacterial isolates from diseased Nile tilapia in Egypt and found that S. agalactiae exhibited high resistance to tetracycline and sulfamethoxazole-trimethoprim. Assane et al. [2] detected antimicrobial resistance genes, including tetM, ermB, and mefA, in Brazilian isolates, correlating with phenotypic resistance. Jantrakajorn et al. [4] noted that Thai isolates were susceptible to enrofloxacin and florfenicol but showed variable resistance to oxytetracycline. These findings underscore the need for routine antimicrobial susceptibility testing to guide treatment decisions and mitigate the spread of resistance.

Conclusion

Streptococcus agalactiae remains a major bacterial pathogen in farmed tilapia worldwide, causing acute and subclinical infections that result in significant economic losses. Clinical outbreaks are driven by a combination of host age, environmental stressors, and the genetic characteristics of the infecting strain. Molecular detection methods, particularly PCR and MLST, have revolutionized the diagnosis and epidemiological surveillance of this pathogen, enabling rapid identification of virulent clones and tracking of AMR patterns. Continued monitoring of serotype and sequence type diversity, along with prudent antimicrobial use, is essential for sustainable tilapia aquaculture. For further reading on related topics, see the article on Streptococcosis in Farmed Tilapia: Streptococcus agalactiae and Streptococcus iniae Pathogenesis, Rapid Diagnostic Tests, and Vaccine Development and the general principles of Antimicrobial Susceptibility Testing in Secondary Viral Co-infections.

References

[1] Rozas-Serri M, Fernandez-Alarcon M, Miyoko-Natori M et al. Streptococcus agalactiae Serotype Ia ST7 CC1 in Farmed Nile Tilapia in Latin America: Age-Dependent Disease Expression and Antimicrobial Susceptibility of an Emerging Clonal Lineage. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198670/

[2] Assane IM, de Oliveira Neto RR, de Abreu Reis Ferreira D et al. Genetic diversity, virulence genes, antimicrobial resistance genes, and antimicrobial susceptibility of group B Streptococcus (GBS) associated with mass mortalities of cultured Nile tilapia in Brazil. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40324602/

[3] Sirimanapong W, Phước NN, Crestani C et al. Geographical, Temporal and Host-Species Distribution of Potentially Human-Pathogenic Group B Streptococcus in Aquaculture Species in Southeast Asia. Pathogens. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37111411/

[4] Jantrakajorn S, Suyapoh W, Wongtavatchai J. Characterization of Lactococcus garvieae and Streptococcus agalactiae in cultured red tilapia Oreochromis sp. in Thailand. J Aquat Anim Health. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38632692/

[5] Legario FS, Choresca CH Jr, Turnbull JF et al. Isolation and molecular characterization of streptococcal species recovered from clinical infections in farmed Nile tilapia (Oreochromis niloticus) in the Philippines. J Fish Dis. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32929781/

[6] Hernández E, Figueroa J, Iregui C. Streptococcosis on a red tilapia, Oreochromis sp., farm: a case study. J Fish Dis. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19236558/

[7] Owatari MS, Jesus GFA, Cardoso L et al. Can histology and haematology explain inapparent Streptococcus agalactiae infections and asymptomatic mortalities on Nile tilapia farms? Res Vet Sci. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/31901532/

[8] Mian GF, Godoy DT, Leal CA et al. Aspects of the natural history and virulence of S. agalactiae infection in Nile tilapia. Vet Microbiol. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19042097/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[9] Barkham T, Zadoks RN, Azmai MNA et al. One hypervirulent clone, sequence type 283, accounts for a large proportion of invasive Streptococcus agalactiae isolated from humans and diseased tilapia in Southeast Asia. PLoS Negl Trop Dis. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31246981/

[10] Diyie RL, Aheto DW, Osei-Atweneboana MY et al. Prevalence of bacterial infections and the use of multiplex PCR assay for rapid detection of pathogens in cultured fish in Ghana. Arch Microbiol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35705871/

[11] Abdelsalam M, Elgendy MY, Shaalan M et al. Rapid identification of pathogenic streptococci isolated from moribund red tilapia (Oreochromis spp.). Acta Vet Hung. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28244330/

[12] Chen M, Li LP, Wang R et al. PCR detection and PFGE genotype analyses of streptococcal clinical isolates from tilapia in China. Vet Microbiol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22677479/

[13] Niu G, Khattiya R, Zhang T et al. Phenotypic and genotypic characterization of Streptococcus spp. isolated from tilapia (Oreochromis spp.) cultured in river-based cage and earthen ponds in Northern Thailand. J Fish Dis. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/31984538/

[14] Pulpipat T, Boonyawiwat V, Moonjit P et al. Streptococcus agalactiae Serotype VII, an Emerging Pathogen Affecting Snakeskin Gourami (Trichogaster pectoralis) in Intensive Farming. Transbound Emerg Dis. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/40303791/

[15] Kawasaki M, Delamare-Deboutteville J, Bowater RO et al. Microevolution of Streptococcus agalactiae ST-261 from Australia Indicates Dissemination via Imported Tilapia and Ongoing Adaptation to Marine Hosts or Environment. Appl Environ Microbiol. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29915111/

[16] Pereira UP, Mian GF, Oliveira IC et al. Genotyping of Streptococcus agalactiae strains isolated from fish, human and cattle and their virulence potential in Nile tilapia. Vet Microbiol. 2010. URL: https://pubmed.ncbi.nlm.nih.gov/19726142/

[17] Hassan MMA, Khalil RH, Abotaleb MM et al. Characterization and antibiogram of bacterial isolates from diseased farmed Nile tilapia in Beheira governorate, Egypt. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41519744/

[18] Evans JJ, Klesius PH, Pasnik DJ et al. Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus). Emerg Infect Dis. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19402966/